-
Clinical Trials Information System (CTIS) webinar
Clinical Trials Information System (CTIS) webinar
-
Clinical Trials Information System (CTIS) webinar
Clinical Trials Information System (CTIS) webinar
EMA will hold a webinar for sponsor organisations (29 July, 14h00-16h30 CEST) to inform them on how to prepare for CTIS. #CTIS4EU
-
CHMP highlights: July 2021
CHMP highlights: July 2021
-
CHMP highlights: July 2021
CHMP highlights: July 2021
EMA’s human medicines committee (CHMP) recommended two medicines for approval at its July 2021 meeting
-
Spikevax approved for adolescents in the EU
Spikevax approved for adolescents in the EU
-
Spikevax approved for adolescents in the EU
Spikevax approved for adolescents in the EU
EMA recommends granting an extension of indication for Spikevax (previously COVID-19 Vaccine Moderna) to include use in children aged 12 to 17
-
Update on safety of COVID-19 Vaccine Janssen
Update on safety of COVID-19 Vaccine Janssen
-
Update on safety of COVID-19 Vaccine Janssen
Update on safety of COVID-19 Vaccine Janssen
Following an EMA review, Guillain Barré syndrome (GBS) will be listed as a very rare side effect of COVID-19 Vaccine Janssen
